http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02085360-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_03621663ff75c4deee4d7cfddcf1851f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_49e186b00b8c4139d21e470e11b335a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_060ac7da25624c3238226238d103d662 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 |
| filingDate | 2002-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49e97b414781939a4afd8eb2593ec5ac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7851524a7bd0e0e7baa56e76f4763139 |
| publicationDate | 2002-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-02085360-A1 |
| titleOfInvention | Optimized procedures for the manufacture of paroxetine salts |
| abstract | Described herein are methods for manufacturing amorphous paroxetine hydrochloride by mixing a carboxylic acid salt of paroxetine with hydrogen chloride and isolating the amorphous paroxetine hydrochloride. Also described herein are methods for manufacturing substantially pure paroxetine free base and methods for obtaining paroxetine salts such as paroxetine acetate, paroxetine trifluoroacetate, and paroxetine formate. Also described are methods for preparing paroxetine carbonate, paroxetine phosphate, paroxetine sulfate, and analogous salts thereof. The paroxetine salts may be formulated for the treatment of medical disorders as described. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006018318-A1 |
| priorityDate | 2001-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 258.